CenterBook Partners
MANE icon

CenterBook Partners’s Veradermics Inc MANE Stock Holding History

CenterBook Partners’s Portfolio MANE Stock Details MANE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-42,357
Closed -$5.21M – 1070
2026
Q2 		$5.21M Buy
+42,357
New +$3.97M 0.26% 102

Other funds holding MANE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

CenterBook Partners's MANE Position: Q3 2026 in Review

CenterBook Partners sold out of Veradermics Inc (MANE) in Q3 2026, closing a stake of 42,357 shares — an estimated $5.21M sold.

CenterBook Partners first reported a position in MANE in Q2 2026 and held it in 1 quarter. The position peaked at $5.21M in Q2 2026. 139 funds tracked by Wall St. Rank hold MANE as of Q3 2026.

  • CenterBook Partners reported no remaining Veradermics Inc position as of Q3 2026 after selling out during the quarter.
  • CenterBook Partners sold 42,357 Veradermics Inc shares in Q3 2026, an estimated $5.21M.
  • CenterBook Partners first reported a position in Veradermics Inc in Q2 2026 and held it in 1 quarter.
  • CenterBook Partners's Veradermics Inc position peaked at $5.21M in Q2 2026.
  • 139 funds tracked by Wall St. Rank held Veradermics Inc as of Q3 2026.

Based on CenterBook Partners's 13F filing for Q3 2026, filed 2 Nov 2026.